Development of an orthotopic human pancreatic cancer xenograft model using ultrasound guided injection of cells

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Huynh, Amanda Shanks ^a   Abrahams, Dominique F ^b   Torres, Monica S ^b   Baldwin, Margaret K ^b   Gillies, Robert J ^a   Morse, David L ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER MODEL; CANCER SIZE; CONTROLLED STUDY; ECHOGRAPHY; FEASIBILITY STUDY; FEMALE; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IN VIVO STUDY; MINIMALLY INVASIVE PROCEDURE; MOLECULAR IMAGING; MOLECULAR PROBE; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PANCREAS CANCER; PERITONEAL CAVITY; PROCESS OPTIMIZATION; REPRODUCIBILITY; TUMOR XENOGRAFT; ULTRASOUND; ANIMAL; CELL STRAIN HCT116; CELL TRANSFORMATION; COMPUTER ASSISTED SURGERY; DISEASE MODEL; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; INJECTION; METASTASIS; METHODOLOGY; PANCREAS; PANCREAS TUMOR; PATHOLOGY; PERITONEUM TUMOR; SPECTROFLUOROMETRY; VASCULARIZATION;

MUS;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; FEMALE; HCT116 CELLS; HUMANS; IMMUNOCOMPROMISED HOST; INJECTIONS; MICE; MOLECULAR IMAGING; PANCREAS; PANCREATIC NEOPLASMS; PERITONEAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, FLUORESCENCE; SURGERY, COMPUTER-ASSISTED; ULTRASONICS;

EID: 79957600437     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020330     Document Type: Article

References (23)

1. Cheon DJ, Orsulic S, Mouse Models of Cancer. Annu Rev Pathol.
2. Morton CL, Houghton PJ, (2007) Establishment of human tumor xenografts in immunodeficient mice. Nat Protoc 2: 247-250.
3. Richmond A, Su Y, (2008) Mouse xenograft models vs GEM models for human cancer therapeutics. Dis Model Mech 1: 78-82.
4. Reynolds, (2005) Assessing Growth and Response to Therapy in Murine Tumor Models. Methods in Molecular Medicine 111.
5. Killion JJ, Radinsky R, Fidler IJ, (1998) Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev 17: 279-284.
6. Altekruse SFKC, Krapcho M, Neyman N, Aminou R, Waldron W, et al.eds. SEER cancer statistics review, 1975-2007. Bethesda, Md. National Cancer Institute Cancer pp. http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010.
7. Vulfovich M, Rocha-Lima C, (2008) Novel advances in pancreatic cancer treatment. Expert Rev Anticancer Ther 8: 993-1002.
8. Ding L, Chen XP, Zhang ZW, Jing K, Zhang WG, (2007) Human multi-drug resistant hepatocellular carcinoma induced in nude mice by B-ultrasonographically-directed orthotopic implantation: a new experimental model. Hepatobiliary Pancreat Dis Int 6: 393-398.
9. Tafreshi NK, Enkemann SA, Bui M, Lloyd MC, Abrahams D, et al. A Mammaglobin-A Targeting Agent for Non-invasive Detection of Breast Cancer Metastasis in Lymph Nodes. Cancer Res.
10. Schneider C, Schmidt T, Ziske C, Tiemann K, Lee KM, et al. (2004) Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model. Gut 53: 355-361.
11. Black KC, Kirkpatrick ND, Troutman TS, Xu L, Vagner J, et al. (2008) Gold nanorods targeted to delta opioid receptor: plasmon-resonant contrast and photothermal agents. Mol Imaging 7: 50-57.
12. Josan JS, Morse DL, Xu L, Trissal M, Baggett B, et al. (2009) Solid-phase synthetic strategy and bioevaluation of a labeled delta-opioid receptor ligand Dmt-Tic-Lys for in vivo imaging. Org Lett 11: 2479-2482.
13. Machado NO, Chopra PJ, Al Hamdani A, Pancreatic metastasis from colon carcinoma nine years after a hemicolectomy managed by distal pancreatectomy. A review of the literature regarding the role and outcome of pancreatic resection for colorectal metastasis. JOP 11: 377-381.
14. Rajput A, Dominguez San Martin I, Rose R, Beko A, Levea C, et al. (2008) Characterization of HCT116 human colon cancer cells in an orthotopic model. J Surg Res 147: 276-281.
15. Flatmark K, Maelandsmo GM, Martinsen M, Rasmussen H, Fodstad O, (2004) Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice. Eur J Cancer 40: 1593-1598.
16. Cespedes MV, Espina C, Garcia-Cabezas MA, Trias M, Boluda A, et al. (2007) Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sites. Am J Pathol 170: 1077-1085.
17. Loukopoulos P, Kanetaka K, Takamura M, Shibata T, Sakamoto M, et al. (2004) Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity. Pancreas 29: 193-203.
18. Snyder CS, Kaushal S, Kono Y, Tran Cao HS, Hoffman RM, et al. (2009) Complementarity of ultrasound and fluorescence imaging in an orthotopic mouse model of pancreatic cancer. BMC Cancer 9: 106.
19. Bouvet M, Wang J, Nardin SR, Nassirpour R, Yang M, et al. (2002) Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Cancer Res 62: 1534-1540.
20. Marincola FM, Drucker BJ, Siao DY, Hough KL, Holder WD Jr, (1989) The nude mouse as a model for the study of human pancreatic cancer. J Surg Res 47: 520-529.
21. Katz MH, Takimoto S, Spivack D, Moossa AR, Hoffman RM, et al. (2003) A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. J Surg Res 113: 151-160.
22. Ding Y, Cravero JD, Adrian K, Grippo P, Modeling pancreatic cancer in vivo: from xenograft and carcinogen-induced systems to genetically engineered mice. Pancreas 39: 283-292.
23. Hausner SH, Abbey CK, Bold RJ, Gagnon MK, Marik J, et al. (2009) Targeted in vivo imaging of integrin alphavbeta6 with an improved radiotracer and its relevance in a pancreatic tumor model. Cancer Res 69: 5843-5850.